Skip to main content
Premium Trial:

Request an Annual Quote

Cadus Technologies Awarded US Patent

Premium
Cadus Technologies has been awarded US Patent 7,361,498, “Yeast cells expressing modified G proteins and methods of use therefore.”
 
The inventors listed on the patent are Dana Fowlkes, James Broach, John Manfredi, Jeremy Paul, Joshua Trueheart, Christine Klein, and Andrew Murphy.
 
According to its abstract, the patent pertains to novel yeast cells that are useful for the expression of heterologous G protein coupled receptors. The yeast cells can be used in assays to screen for modulators of GPCRs. Specifically, the patent describes novel yeast cells that express a heterologous GPCR and mutant and/or chimeric G protein subunit molecules that functionally integrate the heterologous GPCR into the pheromone signaling pathway of the yeast cell. The patent also provides for the expression of heterologous GPCRs that are functionally integrated into the yeast cell membrane using a yeast α-factor leader sequence. Drug discovery assays using these yeast cells are also described.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.